Center for Spatial Systems Biomedicine

Medicine & Life Sciences

1. 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene 15%
2. Adenocarcinoma 14%
3. Androgen Receptors 40%
4. Androgens 9%
5. Atlases 13%
6. Breast 15%
7. Breast Neoplasms 100%
8. Castration 38%
9. Cataloging 14%
10. Cell Line 51%
11. Cell-Free Nucleic Acids 11%
12. Chromatin 12%
13. Computer Simulation 10%
14. Computer-Assisted Surgery 9%
15. Dasatinib 13%
16. Datasets 18%
17. distyrylbenzene 33%
18. Dystroglycans 13%
19. Ectoderm 11%
20. Endocannabinoids 11%
21. Estrogen Receptors 28%
22. Ethanolamines 17%
23. Exome 22%
24. fatty-acid amide hydrolase 14%
25. Fluorescence 39%
26. Fluorescent Dyes 12%
27. Frozen Sections 10%
28. Gene Expression 17%
29. Gene Regulatory Networks 42%
30. Genes 27%
31. Genome 29%
32. Glucocorticoid Receptors 10%
33. Growth 10%
34. Growth Factor Receptors 11%
35. Guanine Nucleotide Dissociation Inhibitors 14%
36. human KAT2A protein 8%
37. Hydrophobic and Hydrophilic Interactions 10%
38. Interleukin-8 9%
39. Kinesin 12%
40. Laminin 10%
41. Lapatinib 29%
42. Learning 10%
43. Libraries 11%
44. Lipids 9%
45. Lysine 9%
46. MDV 3100 41%
47. Melanoma 15%
48. Membranes 10%
49. Micelles 22%
50. Microscopy 52%
51. Microtubules 15%
52. Mitogen-Activated Protein Kinase Kinases 14%
53. Mitogen-Activated Protein Kinases 9%
54. Molecular Models 12%
55. Mutation 34%
56. N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 9%
57. Names 17%
58. Neoplasm Genes 11%
59. Neoplasm Metastasis 12%
60. Neoplasms 59%
61. Neutrophil Activation 11%
62. Neutrophils 14%
63. Nuclear Pore 12%
64. Oncogenes 9%
65. Oxazines 17%
66. p21-Activated Kinases 13%
67. Pharmaceutical Preparations 20%
68. Pharmacogenetics 10%
69. Phenotype 11%
70. Phosphatidylinositol 3-Kinases 24%
71. Phosphoproteins 22%
72. Phosphoric Monoester Hydrolases 9%
73. Phosphorylcholine 12%
74. Poly(ADP-ribose) Polymerase Inhibitors 10%
75. Post Translational Protein Processing 9%
76. Precision Medicine 12%
77. Prostatic Neoplasms 41%
78. Proteins 30%
79. Proto-Oncogene Proteins c-akt 11%
80. Renal Cell Carcinoma 9%
81. rho-Specific Guanine Nucleotide Dissociation Inhibitors 17%
82. Ribosomes 9%
83. Sarcoma 9%
84. Signal Transduction 12%
85. Single Molecule Imaging 44%
86. Small Interfering RNA 14%
87. Spindle Apparatus 11%
88. Structure-Activity Relationship 11%
89. Synaptophysin 11%
90. Systems Analysis 10%
91. Tensins 12%
92. Therapeutics 22%
93. TOR Serine-Threonine Kinases 10%
94. Transcriptome 15%
95. Triple Negative Breast Neoplasms 11%
96. Tumor Cell Line 9%
97. Type C Niemann-Pick Disease 14%
98. Up-Regulation 22%